[1]管志远 综述,张喆** 审校.微创复合式冠状动脉血运重建术现况及进展[J].中国微创外科杂志,2017,17(1):76-79.
　Guan Zhiyuan,Zhang Zhe..The Current Situation and Progress of Minimally Invasive Integrated Coronary Revascularization[J].Chinese Journal of Minimally Invasive Surgery,2017,17(1):76-79.
点击复制

微创复合式冠状动脉血运重建术现况及进展()
分享到：

《中国微创外科杂志》[ISSN:1009-6604/CN:11-4526/R]

卷:
17
期数:
2017年1期
页码:
76-79
栏目:
文献综述
出版日期:
2017-04-18

文章信息/Info

Title:
The Current Situation and Progress of Minimally Invasive Integrated Coronary Revascularization
作者:
管志远 综述; 张喆** 审校
北京大学第三医院心脏外科，北京100083
Author(s):
Guan Zhiyuan;  Zhang Zhe.
Department of Cardiac Surgery, Peking University Third Hospital, Beijing 100083, China
关键词:
微创复合式冠状动脉血运重建术; 小切口冠状动脉旁路移植手术; 经皮冠状动脉介入术
Keywords:
Minimally invasive hybrid coronary revascularization; Minimally invasive coronary artery bypass graft; Percutaneous coronary intervention
文献标志码:
A
摘要:
微创复合式冠状动脉血运重建术是将冠状动脉旁路移植术和经皮冠状动脉介入术联合，用于解决特定的冠状动脉多支病变，理论上具有优于传统冠状动脉旁路移植手术和经皮冠状动脉介入术的优点，但对微创复合式冠状动脉血运重建术的优势缺乏随机对照研究证实，本文对微创复合式冠状动脉血运重建术的基本定义和原理，适应证，手术方式选择，现存的问题进行文献总结。
Abstract:
Minimally invasive hybrid coronary revascularization (MIHCR) represents a minimally invasive revascularization strategy that combines coronary artery bypass graft (CABG) surgery with percutaneous coronary intervention (PCI). Although MIHCR is better than coronary artery bypass graft surgery in theory, there is no useful randomized controlled trial to prove the advantage of MIHCR in recent medical papers. In this paper, we reviewed different aspects of MIHCR, such as basic definitions, basic rationale, indications, operation selection and current problems.

参考文献/References:

[1]Angelini GD,Wilde P,Salerno TA,et al. Integrated left small thoracotomy and angioplasty for multivessel coronary artery revascularisation. Lancet,1996,347(9003):757-758.
[2]Harskamp RE,Bonatti JO, Zhao DX, et al. Standardizing definitions for hybrid coronary revascularization. J Thorac Cardiovasc Surg,2014,147(2):556-560.
[3]Kolh P, Windecker S, Alfonso F, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur J Cardiothorac Surg,2014,46(4):517-592.
[4]Loop FD,Lytle BW,Cosgrove DM,et al. Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. N Engl J Med,1986,314(1):1-6.
[5]Alexander JH, Hafley G, Harrington RA, et al. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. JAMA,2005,294(19):2446-2454.
[6]Navarese EP, Tandjung K, Claessen B, et al. Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis. BMJ,2013,347（6）:6530-6547.
[7]Head SJ, Kaul S, Mack MJ, et al. The rationale for heart team decision-making for patients with stable, complex coronary artery disease. Eur Heart J,2013,34 (32):2510-2518.
[8]Sianos G, Morel MA, Kappetein AP, et al. The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention,2005,1(2):219-227.
[9]Bonatti J, Lehr E, Vesely MR, et al. Hybrid coronary revascularization: which patients? When? How? Curr Opin Cardiol,2010,25(6):568-574.
[10]Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg,2012,143(1):4-34.
[11]杨航，凌云鹏，张鲁峰，等. 分站式杂交手术治疗冠心病多支病变的可行性及安全性分析.中国循环杂志，2016，31(2):113-115.
[12]万峰，王怀军，郝建潮，等.四种不同类型的微创小切口冠状动脉搭桥术.北京医学,2003,25（1）:42-44.
[13]Halkos ME, Vassiliades TA, Douglas JS, et al. Hybrid coronary revascularization versus off-pump coronary artery bypass grafting for the treatment of multivessel coronary artery disease. Ann Thorac Surg, 2011,92(5):1695-1701.
[14]Shen L, Hu S, Wang H, et al. One-stop hybrid coronary revascularization versus coronary artery bypass grafting and percutaneous coronary intervention for the treatment of multivessel coronary artery disease: 3-year follow-up results from a single institution. J Am Coll Cardiol, 2013 25,61(25):2525-2533.
[15]Kon ZN, Brown EN, Tran R, et al. Simultaneous hybrid coronary revascularization reduces postoperative morbidity compared with results from conventional off-pump coronary artery bypass. J Thorac Cardiovasc Surg, 2008,135（1）:367-375.
[16]Hu S, Li Q, Gao P, et al. Simultaneous hybrid revascularization versus off-pump coronary artery bypass for multivessel coronary artery disease. Ann Thorac Surg,2011 ，91(2):432-438.
[17]Modrau IS, Holm NR, Mng M, et al. One-year clinical and angiographic results of hybrid coronary revascularization；J Thorac Cardiovasc Surg,2015,150(5):1181-1186.
[18]高卿，凌云鹏，卢明喻，等.择期分站式杂交手术与非体外循环冠状动脉旁路移植治疗冠状动脉多支血管病变的对比研究. 中国微创外科杂志，2015，15（9）：961-964.
[19]杨明，高长青，刘帅,等.机器人分站式杂交技术治疗冠心病的近期随访.南方医科大学学报,2015,35(8):1166-1169.
[20]Gasior M, Zembala MO, Tajstra M, et al. Hybrid revascularization for multivessel coronary artery disease. JACC Cardiovasc Interv,2014,7(11):1277-1283.
[21]Hu FB, Cui LQ. Short-term clinical outcomes after hybrid coronary revascularization versus off-pump coronary artery bypass for the treatment of multivessel or left main coronary artery disease: a meta-analysis. Coron Artery Dis, 2015，26(6):526-534.

备注/Memo

备注/Memo:
基金项目：Indentifying smooth muscle specific proteins as biomarkers for early diagnosis of acute aortic dissection(项目编号：A75510-03)**通讯作者，E-mail:zhangzhe@bjmu.edu.cn
更新日期/Last Update: 2017-04-18